Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Frontiers in Oncology|August 15, 2022
Editorial: Immunotherapy in renal cell carcinomaViktor Gruenwald, Walter J Storkus
Annals of Surgical Oncology|February 11, 2016
Correlation of CTNNB1 Mutation Status with Progression Arrest Rate in RECIST Progressive Desmoid-Type Fibromatosis Treated with Imatinib: Translational Research Results from a Phase 2 Study of the German Interdisciplinary Sarcoma Group (GISG-01)Bernd Kasper, Viktor Gruenwald, Peter Reichardt, et al.
BMC Cancer|January 4, 2011
Circulating endothelial cells are an early predictor in renal cell carcinoma for tumor response to sunitinibViktor Gruenwald, Gernot Beutel, Susanne Schuch-Jantsch, et al.
Onkologie|April 18, 2009
Phase II trial of capecitabine and oxaliplatin in patients with adeno- and undifferentiated carcinoma of unknown primaryKatharina Schuette, Gunnar Folprecht, Albrecht Kretzschmar, et al.
European Journal of Cancer (Oxford, England : 1990)|March 11, 2017
Imatinib induces sustained progression arrest in RECIST progressive desmoid tumours: Final results of a phase II study of the German Interdisciplinary Sarcoma Group (GISG)Bernd Kasper, Viktor Gruenwald, Peter Reichardt, et al.
BMC Cancer|April 18, 2015
Study protocol of REGOSARC trial: activity and safety of regorafenib in advanced soft tissue sarcoma: a multinational, randomized, placebo-controlled, phase II trialThomas Brodowicz, Bernadette Liegl-Atzwager, Emmanuelle Tresch, et al.
Journal for Immunotherapy of Cancer|April 5, 2019
Comparative analysis of the phase III clinical trials of anti-PD1 monotherapy in head and neck squamous cell carcinoma patients (CheckMate 141 and KEYNOTE 040)Sara I Pai, Sandrine Faivre, Lisa Licitra, et al.
Future Oncology (London, England)|September 23, 2020
Consensus paper: current state of first- and second-line therapy in advanced clear-cell renal cell carcinomaPeter J Goebell, Philipp Ivanyi, Jens Bedke, et al.
The Canadian Journal of Urology|June 19, 2012
Positive effects of zoledronate on skeletal-related events in patients with renal cell cancer and bone metastasesUlf W Tunn, Amulf Stenzl, Wolfgang Schultze-Seemann, et al.
ESMO Open|July 17, 2020
Impact of COVID-19 pandemic on treatment patterns in metastatic clear cell renal cell carcinomaStefanie Aeppli, Eric Innocents Eboulet, Tim Eisen, et al.
Pageof 2